Copyright
©The Author(s) 2024.
World J Virol. Sep 25, 2024; 13(3): 91107
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.91107
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.91107
Rhabdomyolysis (n = 15) | Other AKI (n = 100) | P value | |
Peak creatinine (mg/dL) | 2.47 ± 1.17 | 1.62 ± 0.58 | 0.000 |
Mean arterial pressure (mmHg) | 89.75 ± 8.63 | 88.63 ± 14.38 | 0.790 |
Hemoglobin (g/dL) | 12.59 ± 1.83 | 12.26 ± 1.83 | 0.560 |
Lymphocytes (μL) | 941.60 ± 311.70 | 1362.30 ± 676.10 | 0.010 |
Nadir lymphocytes (μL) | 533.30 ± 280.60 | 957.90 ± 618.80 | 0.020 |
CRP (mg/L) | 111.12 ± 69.91 | 77.45 ± 78.41 | 0.140 |
Peak CRP (mg/dL) | 253.24 ± 80.67 | 156.95 ± 111.20 | 0.000 |
Procalcitonin (ng/mL) | 0.28 [0.12-0.75] | 0.10 [0.06-0.28] | 0.018 |
Peak procalcitonin (ng/mL) | 1.61 [0.40-10.60] | 0.16 [0.08-1.03] | 0.002 |
Creatine kinase (U/L) | 260.00 [123.50-1057.20] | 94.50 [58.0-203.70] | 0.005 |
Peak CK (U/L) | 1929.30 ± 1282.20 | 238.10 ± 237.0 | 0.000 |
Median: 1514.0 | Median: 126.50 | ||
Ferritin (ng/mL) | 669.0 [195.90-1403.50] | 366.00 [192.50-884.0] | 0.360 |
Peak ferritin (ng/mL) | 1320.10 ± 590.0 | 967.10 ± 1038.70 | 0.020 |
Median: 1267.50 | Median: 657.0 | ||
LDH (U/L) | 469.40 ± 162.70 | 408.00 ± 350.0 | 0.550 |
Peak LDH (U/L) | 964.90 ± 409.60 | 654.70 ± 61.80 | 0.030 |
Albumin (g/dL) | 3.15 ± 0.49 | 3.44 ± 0.49 | 0.057 |
D-dimer (μg FEU/mL) | 1.62 ± 1.34 | 1.93 ± 3.17 | 0.730 |
Peak d-dimer (μg FEU/mL) | 23.40 ± 22.50 | 7.90 ± 11.07 | 0.030 |
Uric acid (mg/dL) | 4.85 ± 2.18 | 5.81 ± 2.18 | 0.160 |
HCO3- (mmol/L) | 21.51 ± 8.71 | 24.98 ± 4.53 | 0.220 |
- Citation: Murt A, Altiparmak MR. Rhabdomyolysis-related acute kidney injury in patients with COVID-19. World J Virol 2024; 13(3): 91107
- URL: https://www.wjgnet.com/2220-3249/full/v13/i3/91107.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i3.91107